.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Argus Health
Fuji
Cipla
Colorcon
Farmers Insurance
Novartis
Federal Trade Commission
McKinsey

Generated: July 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089515

« Back to Dashboard
NDA 089515 describes VINBLASTINE SULFATE, which is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, Hospira, and West-ward Pharms Int, and is included in four NDAs. It is available from one supplier. Additional details are available on the VINBLASTINE SULFATE profile page.

The generic ingredient in VINBLASTINE SULFATE is vinblastine sulfate. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vinblastine sulfate profile page.

Summary for NDA: 089515

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 089515

Ingredient-typeVinca Alkaloids

Suppliers and Packaging for NDA: 089515

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VINBLASTINE SULFATE
vinblastine sulfate
INJECTABLE;INJECTION 089515 ANDA Fresenius Kabi USA, LLC 63323-278 63323-278-10 1 VIAL, MULTI-DOSE in 1 BOX (63323-278-10) > 10 mL in 1 VIAL, MULTI-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/ML
Approval Date:Apr 29, 1987TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Chubb
Moodys
Baxter
Julphar
Chinese Patent Office
Boehringer Ingelheim
Federal Trade Commission
Deloitte
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot